Inhibikase Therapeutics Inc. (IKT)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 6,325,000 $13,851,750 1%
2.
Perceptive Advisors

Joseph Edelman

5,925,000 $12,975,750 0.46%
3.
Commodore Capital

Egen Atkinson And Michael Kramarz

5,344,432 $11,704,306 -10% 0.86%
4.
ADAR1 Capital Management

Daniel Schneeberger

5,122,105 $11,217,410 +1% 2.08%
5.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

2,190,000 $4,796,100 0.19%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.37 1,460,000 1,460,000 2024-10-21 Filing
$1.37 145,000 145,000 2024-10-21 Filing
$1.37 365,000 365,000 2024-10-21 Filing
$0.80 5,000 Large Shareholder, Officer, Director 5,335,433 2022-08-16 Filing
$0.98 5,000 Large Shareholder, Officer, Director 5,330,433 2022-05-27 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 10,950,000 $23,980,500 5.86%
2. 6,125,000 $13,413,750 2.08%
3. 2,848,663 $6,238,572 0%
4. 2,070,684 $4,534,798 0.02%
5. 504,625 $1,105,129 0%
News See All